Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2014, Article ID 260485, 5 pages
http://dx.doi.org/10.1155/2014/260485
Research Article

Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA

1Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, La Fama, 14269 Mexico City, Mexico
2Movement Disorders Clinic, National Institute of Neurology and Neurosurgery, 14269 Mexico City, Mexico
3National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, 30201 Madrid, Spain

Received 2 September 2014; Revised 7 October 2014; Accepted 10 October 2014; Published 23 October 2014

Academic Editor: Heinz Reichmann

Copyright © 2014 Mayela Rodríguez-Violante et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Weintraub and D. J. Burn, “Parkinson's disease: the quintessential neuropsychiatric disorder,” Movement Disorders, vol. 26, no. 6, pp. 1022–1031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. F. G. Leentjens, K. Dujardin, L. Marsh et al., “Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 23, no. 14, pp. 2004–2014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Schrag, P. Barone, R. G. Brown et al., “Depression rating scales in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 22, no. 8, pp. 1077–1092, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. Fernandez, D. Aarsland, G. Fénelon et al., “Scales to assess psychosis in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 23, no. 4, pp. 484–500, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. F. G. Leentjens, K. Dujardin, L. Marsh et al., “Anxiety rating scales in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 23, no. 14, pp. 2015–2025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Gallagher, C. G. Goetz, G. Stebbins, A. J. Lees, and A. Schrag, “Validation of the MDS-UPDRS part I for nonmotor symptoms in Parkinson's disease,” Movement Disorders, vol. 27, no. 1, pp. 79–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Martinez-Martin, K. R. Chaudhuri, J. M. Rojo-Abuin et al., “Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale,” European Journal of Neurology, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Martinez-Martin, B. Frades-Payo, L. Agüera-Ortiz, and A. Ayuga-Martinez, “A short scale for evaluation of neuropsychiatric disorders in Parkinson’s disease: first psychometric approach,” Journal of Neurology, vol. 259, no. 11, pp. 2299–2308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. R. G. Gibb and A. J. Lees, “The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 51, no. 6, pp. 745–752, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Martinez-Martin, C. Rodriguez-Blazquez, M. Alvarez-Sanchez et al., “Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS),” Journal of Neurology, vol. 260, no. 1, pp. 228–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. McHorney and A. R. Tarlov, “Individual-patient monitoring in clinical practice: are available health status surveys adequate?” Quality of Life Research, vol. 4, no. 4, pp. 293–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. F. A. van der Linden, J. J. Kragt, M. Klein, H. M. van der Ploeg, C. H. Polman, and B. M. J. Uitdehaag, “Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 12, pp. 1677–1681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Hobart, A. Riazi, D. L. Lamping, R. Fitzpatrick, and A. J. Thompson, “Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome,” Health Technology Assessment, vol. 8, article 9, 2004. View at Google Scholar · View at Scopus
  16. N. Aaronson, J. Alonso, A. Burnam et al., “Assessing health status and quality-of-life instruments: attributes and review criteria,” Quality of Life Research, vol. 11, no. 3, pp. 193–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. D. Simon, Statistical Evidence in Medical Trials, Oxford University Press, Oxford, UK, 2006. View at MathSciNet
  18. D. Weintraub, “Impulse control disorders in Parkinson's disease: prevalence and possible risk factors,” Parkinsonism and Related Disorders, vol. 15, supplement 3, pp. S110–S113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Weintraub, J. Koester, M. N. Potenza et al., “Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients,” Archives of Neurology, vol. 67, no. 5, pp. 589–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Weintraub, E. Mamikonyan, K. Papay, J. A. Shea, S. X. Xie, and A. Siderowf, “Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale,” Movement Disorders, vol. 27, no. 2, pp. 242–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Aarsland, J. P. Larsen, E. Tandberg, and K. Laake, “Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study,” Journal of the American Geriatrics Society, vol. 48, no. 8, pp. 938–942, 2000. View at Google Scholar · View at Scopus
  22. S. A. Factor, P. J. Feustel, J. H. Friedman et al., “Longitudinal outcome of Parkinson's disease patients with psychosis,” Neurology, vol. 60, no. 11, pp. 1756–1761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. F. Pedersen, G. Alves, D. Aarsland, and J. P. Larsen, “Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 11, pp. 1279–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Aarsland, L. Marsh, and A. Schrag, “Neuropsychiatric symptoms in Parkinson's disease,” Movement Disorders, vol. 24, no. 15, pp. 2175–2186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. M. Wichowicz, J. Sławek, M. Derejko, and W. J. Cubała, “Factors associated with depression in Parkinson's disease: a cross-sectional study in a Polish population,” European Psychiatry, vol. 21, no. 8, pp. 516–520, 2006. View at Publisher · View at Google Scholar · View at Scopus